In August 2023, the U.S. Department of Health and Human Services announced the first 10 drugs covered under Medicare Part D ...

President Joe Biden’s Inflation Reduction Act allows Medicare to negotiate costly drug prices with pharmaceutical companies.

Danish drugmaker Novo Nordisk expects its diabetes drug Ozempic will "very likely" be on the U.S. government's 2027 list of ...

This news of Ozempic price cuts comes on the heels, or tablet, of Novo Nordisk developing a weight loss pill that mirrors the ...

A top executive at Novo Nordisk (NVO) warned Tuesday that the company’s diabetes therapy Ozempic will likely be selected for ...

Will Medicare Part D cover Ozempic? Read on to learn more about when Medicare may provide coverage for Ozempic or other ...

CMS will announce maximum fair prices for these drugs by November 30, 2025, with negotiated prices available on January 1, ...

Ozempic, the blockbuster diabetes shot made by Novo Nordisk A/S, is “very likely” to be one of the next drugs targeted for a ...

Americans are paying more than $900 a month for popular weight-loss drugs Ozempic and Wegovy, but drugmakers want to sell ...

The latest health news includes Sen. Sanders advocating for affordable Ozempic, Neuralink's FDA 'breakthrough' for Blindsight ...

Novo Nordisk has multiple, strong upcoming, positive catalysts, related to its GLP-1 weight-loss drugs, Ozempic and Wegovy.